Summary & Overview
CPT 11921: Medical Tattooing for Permanent Camouflage of Skin Defects
CPT code 11921 represents medical tattooing (permanent camouflage) of a localized skin defect measuring 6.1 to 20.0 cm² using intradermal insoluble opaque pigments. This procedure addresses pigmentary abnormalities arising from congenital conditions, burns, vitiligo, birthmarks, and post-reconstructive needs such as nipple-areola complex restoration after breast reconstruction. Nationally, the code matters because it defines a discrete, billable service that intersects dermatology, plastic and reconstructive surgery, and cosmetic restoration care, with implications for clinical documentation, coverage determinations, and outpatient procedural billing.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical context for using 11921, typical settings where the service is delivered, and what payers commonly consider when adjudicating claims for medical tattooing. The report summarizes benchmarks and coverage considerations, highlights common billing modifiers and claim line practices, and outlines areas where coding clarity and consistent documentation influence reimbursement outcomes. Where input data is missing, the publication notes that those specific details are not available in the source material. The content is written for a national audience and is intended to support coding, billing, and policy professionals in understanding the scope and use of CPT code 11921.
Billing Code Overview
CPT code 11921 describes a medical tattooing procedure in which the provider applies intradermal insoluble opaque pigments to an area of skin measuring 6.1 to 20.0 cm² to correct or camouflage skin color defects. Indications include congenital pigmentary defects, post-reconstruction pigmentation needs (such as after breast reconstruction), burns, vitiligo, birthmarks, and other conditions requiring permanent cosmetic camouflage.
Service Type: Medical tattooing / permanent camouflage of skin defects
Typical Site of Service: Outpatient dermatology or plastic surgery clinic, ambulatory surgical center, or specialty office setting
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 42-year-old female patient presents to a dermatology/plastic surgery ambulatory clinic for color-corrective micropigmentation (medical tattooing) of the areola following unilateral mastectomy and implant-based breast reconstruction. The patient has healed surgical wounds, stable reconstruction, and persistent hypopigmented or absent areolar tissue causing cosmetic and psychosocial concerns. The clinical workflow includes pre-procedure counseling, informed consent, marking and measurement of the treatment area (confirming size between 6.1 and 20.0 cm2), selection of sterile, intradermal opaque pigments matched to the contralateral areola, local anesthesia as needed, sterile technique during tattooing, immediate post-procedure wound care instructions, and a plan for potential touch-up sessions. Typical site of service is an outpatient dermatology or plastic surgery clinic procedure room; anesthesia is usually local, and the encounter is commonly billed as an office-based procedure. Typical documentation includes pre-procedure history and indication, measurements of the treated area, pigment color and lot, consent, procedural description of intradermal placement, any anesthesia used, estimated blood loss (if applicable), complications (if any), and post-procedure instructions and follow-up plan.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Normal procedural service | Use when this is the usual, uncomplicated service provided by the billing practitioner. |
22 | Increased procedural services | Use when work required to perform the procedure is substantially greater than typical (extensive scarring, revision complexity). |
23 | Unusual anesthesia | Use if general anesthesia or deep sedation was medically necessary and not normally required. |
26 | Professional component | Use if billing only for the physician professional component when another entity provides technical component (rare for office tattooing). |
50 | Bilateral procedure | Use if the same procedure is performed bilaterally (e.g., both areolae on reconstructions when applicable). |
51 | Multiple procedures | Use when the tattooing is billed in the same session with other distinct procedures. |
52 | Reduced services | Use when the procedure is partially reduced or not completed as planned. |
53 | Discontinued procedure | Use when procedure was started but stopped due to complications or patient intolerance. |
59 | Distinct procedural service | Use to indicate a separate, distinct procedure or service performed at a different site or anatomical region the same day. |
62 | Two surgeons | Use when two surgeons of different specialties actively participate in a single procedure. |
63 | Procedure performed on infants less than 4 kg | Use when applicable to neonatal patients. |
76 | Repeat procedure by same physician | Use when the same procedure is repeated by the same physician during the postoperative period (not in provided list; omitted). |
78 | Unplanned return to the operating/procedure room | Use when patient must return during the global period for a related procedure due to complication. |
TC | Technical component | Use when billing only for technical services if another provider bills professional component. |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
| 207P00000X | Dermatology | Dermatologists commonly perform medical tattooing for pigmentary restoration and vitiligo camouflage. |
| 208100000X | Plastic Surgery | Plastic surgeons perform areolar tattooing after breast reconstruction and scar camouflage. |
| 2084P0800X | Cosmetic Surgery | Cosmetic surgeons or cosmetic proceduralists may perform medical tattooing for reconstructive and aesthetic indications. |
| 363A00000X | Anesthesiology | Anesthesiologists or CRNAs may be involved if deeper sedation or general anesthesia is required for complex cases. |
| 207K00000X | Family Medicine | Some family medicine physicians with procedural training may perform medical tattooing in outpatient settings. |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
L91.8 | Other hypertrophic disorders of skin | Relevant when tattooing is used to camouflage scar-related pigmentation changes after burns or surgery. |
Q82.5 | Pigmentary mosaicism | Relevant for congenital pigmentary defects where micropigmentation can improve appearance. |
L80 | Vitiligo | Direct indication for medical tattooing to restore color to depigmented areas. |
T20.0 | Burn of face and neck, unspecified degree | Representative burn diagnosis where tattooing may be used for camouflage of hypopigmented or scarred skin. |
D22.9 | Melanocytic nevus, unspecified | May be relevant when tattooing is used after excision and reconstruction to restore surrounding skin appearance. |
Z42.0 | Encounter for breast reconstruction following mastectomy | Common scenario where areolar tattooing (11921) is performed to complete reconstruction. |
Q82.1 | Congenital nonneoplastic nevus | Relevant for congenital birthmarks where pigment restoration or color blending is indicated. |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
11920 | Tattooing, intradermal introduction of insoluble opaque pigment, per session; area(s) greater than 2.0 sq cm, up to 6.0 sq cm | Used for smaller treatment areas; may be billed when the tattooed area measures 2.1–6.0 cm2 instead of the 11921 size range. |
15770 | Punch grafting of skin | May be performed in conjunction with reconstruction for scar revision or pigmentary correction prior to or instead of micropigmentation in some cases. |
15775 | Full-thickness skin graft; for reconstruction of facial defects (e.g., complex scar/defect reconstruction) | May be part of a staged reconstructive plan where tattooing is performed as a final camouflaging step. |
11922 | Tattooing, intradermal introduction of insoluble opaque pigment, per session; each additional 20.0 sq cm, or part thereof | Used when a larger contiguous area beyond 11921 requires additional billing for added area. |
99070 | Supplies and materials (except spectacles), provided by the physician over and above those usually included with the office visit or procedure | Used to report external disposable supplies (sterile pigment kits, needles) when payer contract requires separate supply reporting. |